Failure of detection of the tyrosine to histidine substitution at the residue 33 of thymidylate synthase in human colorectal cancer. A preliminary study

Anticancer Research

Volumn 20, Issue 6 B, 2000, Pages 4347-4350

  Sanguedolce, R ^a   Alessandro, R ^a   De Leo, G ^a   Gullotti, L ^a   Sanguedolce, F ^a   Vultaggio, G ^a   Diana, G ^a   Cirello, B ^a   Rausa, L ^a  

^a Policlinico Universitario   (Italy)

Author keywords

5 fluorouracil resistance; Human colorectal cancer; Point mutation; Thymidylate synthase

Indexed keywords

FLOXURIDINE; FLUOROPYRIMIDINE; FLUOROURACIL; HISTIDINE; THYMIDYLATE SYNTHASE; TYROSINE;

ADULT; AGED; ARTICLE; CANCER CELL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENETIC VARIABILITY; HUMAN; MACROMOLECULE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; AGED; COLONIC NEOPLASMS; FEMALE; HISTIDINE; HUMANS; MALE; NEOPLASM PROTEINS; NEOPLASM STAGING; POINT MUTATION; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDYLATE SYNTHASE; TYROSINE;

EID: 0034484473     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2′deoxyuridine in mammalian and bacterial cells
2. Cancer statistics
3. Chemotherapy for colorectal cancer
4. The classification of cancer of the rectutn
5. The grading of carcinoma
6. Survival and response to chemotherapy for advanced colorectal adenocarcinoma: An Eastern Cooperative Oncology Group Report
7. 5-fluorouracil: Biochemistry and pharmacology
8. Understanding the actions of carcinostatic drugs to improve chemotherapy: 5-fluorouracil
9. Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man
10. Fluorinated pyrimidines and their nucleosides
11. Mechanism of interaction of thymidylate synthase with 5-fluorodeoxyuridylate
12. Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase
13. Tight-binding complexes of thymidylate synthetase, folate analogs and deoxyribonucleotides
14. Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant Ehrlich ascites carcinoma cells
15. Human leukemic cells resistant to 5-fluoro-2′-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides
16. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates
17. Thymidylate synthase as a determinant of 5-fluoro-2′-deoxyuridine response in human colonic tumor cell lines
18. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2′-deoxyuridine in a human colonic tumor cell line
19. Single amino acid substitution defines a naturally occurring genetic variant of human thymidylate synthase